Meeting to be held in Chicago on April 8 and in San Francisco on April 9 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IONS:
- Promising Potential of Ionis Pharmaceuticals’ Pelacarsen Drives Buy Rating Amidst Phase 3 HORIZON Trial Optimism
- Ionis Pharmaceuticals initiated with a Neutral at Redburn Atlantic
- Ionis Pharmaceuticals enters exclusive olezarsen license agreement with Sobi
- Ionis Pharmaceuticals price target lowered to $45 from $47 at JPMorgan
- Metagenomi price target lowered to $20 from $25 at Wells Fargo